Identifying high-risk patients among those with DM that are prone to the occurrence of HF, can establish the initiation of more intense preventive measures, including medicine up-titration of renin–angiotensin system antagonists or the introduction of novel therapies of HF for patients with preserved ejection fraction. The gene discussed is REN; the disease is hydrops fetalis.